Question 1

What is Actinium Pharmaceuticals?

Accepted Answer

Actinium Pharmaceuticals is a Company.

Question 2

How often does Actinium Pharmaceuticals appear in global news?

Accepted Answer

Tracked across 3 news events drawn from 18 articles.

Question 3

When was Actinium Pharmaceuticals first tracked by NewsDesk?

Accepted Answer

First tracked on Mar 28, 2025.

Question 4

When was Actinium Pharmaceuticals last mentioned in news?

Accepted Answer

Last active on Apr 24, 2025.

Question 5

What is Actinium Pharmaceuticals's current news sentiment?

Accepted Answer

Aggregate sentiment score: -53 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Actinium Pharmaceuticals in global news coverage?

Accepted Answer

Attention score of 3, derived from article volume and coverage intensity across 3 events.

Question 7

What is the most recent event involving Actinium Pharmaceuticals?

Accepted Answer

Actinium Pharmaceuticals Class Action Lawsuit Filed (Mar 28, 2025, 6 articles).

Question 8

Who is Actinium Pharmaceuticals most connected to?

Accepted Answer

Top relationships: United States — Food and Drug Administration, United States — Food and Drug Administration.

Question 9

How did the "Actinium Pharmaceuticals Class Action Lawsuit Filed" event impact Actinium Pharmaceuticals?

Accepted Answer

Actinium Pharmaceuticals is the defendant in a class action lawsuit alleging misleading statements regarding its Iomab-B Biologics License Application and Sierra Trial data, which could lead to significant financial and reputational damage.

Question 10

How did the "Actinium Pharmaceuticals Class Action Lawsuit" event impact Actinium Pharmaceuticals?

Accepted Answer

Actinium Pharmaceuticals is facing a class action lawsuit for allegedly issuing materially false and/or misleading statements regarding its Iomab-B BLA and the Phase 3 Sierra trial data, which could negatively impact its stock price and reputation.

Question 11

How did the "Actinium Pharmaceuticals Faces Securities Lawsuit" event impact Actinium Pharmaceuticals?

Accepted Answer

Actinium Pharmaceuticals is the defendant in a class action securities lawsuit, facing allegations of making false and misleading statements regarding its Iomab-B BLA and the Sierra trial data, which could negatively impact its stock price and reputation.

Question 12

How is this data collected?

Accepted Answer

NewsDesk aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.